LTZ Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in LTZ Therapeutics?

LTZ Therapeutics has 17 investors including Unicorn Capital Partners And Lanchi Ventures.

Q: When was the last funding round for LTZ Therapeutics?

LTZ Therapeutics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has LTZ Therapeutics raised to date?

LTZ Therapeutics has raised obfuscated.

Overview

LTZ Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About LTZ Therapeutics

CB Rank

2048

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Founded

obfuscation

Private

Venture - Series Unknown

San Francisco, California, United States

11-50

www.ltztherapeutics.com/

Biotechnology

Health Care

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Corporate Round

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Robert Li: Founder and CEO

Details

Legal Name

LTZ Therapeutics Inc.

Also Known As

Zean Biomedical, Zean Biopharmaceuticals, 泽安生物医药

Operating Status

Active

Company Type

For Profit

Founders

Robert Li

About the Company

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Predictions & Insights

Growth Insight

See this Growth Insight

LTZ Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Innate Engager Platform

A platform designed to activate macrophages and NK cells for direct anti-tumor and anti-immunosuppressive cell killing, promoting inflammation in the tumor microenvironment.

LTZ-301

A therapy under development for NHL, FL, CLL, and autoimmune diseases with global ownership.

Research & Development

LTZ Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown
obfuscated obfuscation	Venture Round - LTZ Therapeutics	6	obfuscated obfuscation	GL Ventures LLC	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Unicorn Capital Partners	—	Venture Round - LTZ Therapeutics	—
Unicorn Capital Partners	—	Venture Round - LTZ Therapeutics	—
Unicorn Capital Partners	—	Venture Round - LTZ Therapeutics	—
Unicorn Capital Partners	—	Venture Round - LTZ Therapeutics	—
Unicorn Capital Partners	—	Venture Round - LTZ Therapeutics	—